<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15843">Arachidonic acid</z:chebi> [20:4(N-6)] has been implicated in neurological damage induced by <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Membrane <z:chebi fb="0" ids="32395">arachidonate</z:chebi> concentrations can be reduced by changes in dietary fat intake </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, in the present study, we have investigated the effects of N-3 fatty acid supplementation on neuronal damage induced by permanent focal <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> or pharmacological activation of striatal <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
<SENT sid="3" pm="."><plain>Weanling rats were fed either a control diet or an N-3 supplemented diet (1.75% by weight as N-3 fatty acids) for 6 weeks </plain></SENT>
<SENT sid="4" pm="."><plain>N-3-supplemented animals reduced ischaemic damage following middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (36%, p &lt; 0.05), and excitotoxic damage induced by infusion of the selective <z:chebi fb="0" ids="31882">NMDA</z:chebi> <z:chebi fb="4" ids="48705">agonist</z:chebi> (1-aminocyclobutane-cis-1,3-<z:chebi fb="0" ids="35692">dicarboxylic acid</z:chebi>, 43%, p &lt; 0.001) compared to the control-fed group </plain></SENT>
<SENT sid="5" pm="."><plain>These data are consistent with the proposed role of <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> in ischaemic and excitotoxic brain damage, and suggest that modest dietary supplementation with N-3 fatty acids may offer benefit to populations at high risk of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>